Announcements Trials

Browse Landscape

Phase

Status

Unknown 3 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 17 Triple Negative Breast Neoplasms 9 Urinary Bladder Neoplasms 1 Resectable HER2-positive Breast Cancer 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplastic Cells, Circulating 1 Multiple Myeloma 1 Lymphoma, T-Cell, Peripheral 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 HR-positive,HER2-negative Breast Cancer 1 HR+/HER2- Breast Cancer 1 HER2-negative Early Breast Cancer 1 HER2-negative Breast Cancer 1 HER2 Positive Early Breast Cancer 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Adenoid Cystic 1

Interventions

pembrolizumab 20 Gemcitabine 18 Cisplatin 14 Magnetic Resonance Spectroscopy 13 enfortumab vedotin 12 Specimen Handling 10 Cystectomy 10 Docetaxel 8 Mitomycin 7 Standard of Care 6 Cystoscopy 6 Transurethral Resection of Bladder 5 Radiotherapy 5 Carboplatin 5 durvalumab 4 Practice Guidelines as Topic 4 Nivolumab 4 Radiation 3 Multiparametric Magnetic Resonance Imaging 3 Mitozytrex 3 Fluorouracil 3 tislelizumab 2 dehydroftorafur 2 cemiplimab 2 avelumab 2 alvimopan 2 Therapeutics 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Radiosurgery 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Urinary Bladder Neoplasms × Epirubicin × Clear all

NCT05024734 2025-03-11

GAIN INST

Hospital Centre Biel/Bienne

Phase 2 Recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡